3G4-14855-60998
2 vaccinations
2 coded responses
8 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 970 / OR
- Registered
- 2021-10-31
- Relationship
- Adult relative or friend
- Guardian
- ZSZ-18217-53621
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Dose 1 — Janssen/Johnson & Johnson
-
2021-10-29
Dose 2 — Moderna
-
2021-10-31
Registered in v-safe
-
2021-10-31
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-11-02
- 2021-11-04
- 2021-11-12
-
2021-11-26
Survey response — day 28, dose 2, dependentMedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: ColdMedDRA releases: 2024-11 · check-in free text available
- 2022-01-28
- 2022-05-01
-
2022-10-31
Survey response — 12 months, dose 2, dependentMedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid 19MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Janssen/Johnson & Johnson | No |
| 2 | 2021-10-29 | Moderna | No |
Free text
Release 10 — day 28, dose 2, dependent
Symptoms: Cold
Release 12 — 12 months, dose 2, dependent
Symptoms: Covid 19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release